⟵ Back to Search Results

BGB-16673-102

Recruiting

Treatment of Chinese Patients With B-Cell Malignancies With BGB-16673, a Burton Tyrosine Kinase-Targeted Protein-Degrader

Beigene Study ID info

BGB-16673-102

ClinicalTrials.gov ID info

NCT05294731

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years and older   (Adult, Older Adult)

No Study Documents